Prenatal Betamethasone Exposure and its Impact on Pediatric Type 1 Diabetes Mellitus: A Preliminary Study in a Spanish Cohort
Table 2
Variable distribution depending on betamethasone treatment.
Variable
Betamethasone
Total
-value
No
Yes
Missing
Birth at weight‡ (kg, ) (P25; P75)
(2.94; 3.60)
(2.02; 3.19)
(2.85; 3.66)
(2.90; 3.60)
0.00001¶
Duration of gestation§ (weeks, ) (P25; P75)
n = 805
(38.00;40.00)
(34.00;38.00)
(37.00;40.00)
(38.00;40.00)
0.00001¶
Sex
Female, (%)
340 (40.4%)
19 (33.9%)
26 (54.2%)
385 (40.8%)
0.0257||
Male, (%)
374 (44.5%)
26 (46.4%)
22 (45.8%)
422 (45.3%)
Missing, (%)
127 (15.1%)
11 (19.6%)
0 (0%)
138 (13.9%)
‡ Birth weight was missing in 20 subjects (2.1%). § Duration of gestation was missing in 39 subjects (4.1%) ¶: ANOVA (analysis of variance). ||: chi-squared test.
